Foley Senior Counsel R. Brian McCaslin authored an article titled “Are Patent Offices Ready for Personalized Medicine?” in the March/April 2009 issue of Bio-IT World. McCaslin discusses the unique challenges to the patent system presented by new sciences such as personalized medicine, stating that innovators seeking to patent new sciences should consider adapting their prosecution strategy to the current administrative landscape. He adds that innovators should consider postponing the filing date of an application until more information about the new science can be obtained.
Related Insights
May 29, 2025
Manufacturing Industry Advisor
Foley Automotive Update
Analysis by Julie Dautermann, Competitive Intelligence Analyst Foley is here to help you through all aspects of rethinking your long-term…
May 29, 2025
Foley Viewpoints
Keep Wining: Franchise Statute Opens Door to Protections for Missouri Wine Distributor
The Eighth Circuit recently applied a novel, broad reading of the Missouri Franchise Act granting franchise protection to distributors…
May 28, 2025
Foley Viewpoints
U.S. and International Antitrust Agencies Signal Aggressive Antitrust Enforcement in Procurement, Consumer Products, and Labor Markets
As we previously reported on April 15 and April 28, the Department of Justice (DOJ) and Federal Trade Commission (FTC) are increasingly…